{"entity":{"type":"insider","cik":"0001609284","url":"/insider/0001609284","json_url":"/insider/0001609284.json","name":"Saccomano Nicholas A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2019-02-08","last":"2026-06-24","span_basis":"filed_date"},"name_variants":[{"name":"Saccomano Nicholas A","source":"filing","n_filings":7,"first_seen":"2019-02-08","last_seen":"2026-06-24"}],"transactions":[{"id":6055279,"accession":"0001609284-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001609284-26-000003","line_url":"/filing/0001609284-26-000003#line-1","is_derivative":false,"issuer_cik":"0001609284","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001609284","owner_cik":"0001609284","owner_name":"Saccomano Nicholas A","owner_display_name":"Saccomano Nicholas A","owner_url":"/insider/0001609284","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86.0,"shares_display":"86","price_per_share":4.3963,"price_display":"4.40","price_state":"stated","total_value":378.0818,"total_display":"378.08","total_whole":"378","shares_owned_after":11247.0,"shares_owned_after_display":"11,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":5801820,"accession":"0001609284-26-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001609284-26-000001","line_url":"/filing/0001609284-26-000001#line-1","is_derivative":false,"issuer_cik":"0001609284","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001609284","owner_cik":"0001609284","owner_name":"Saccomano Nicholas A","owner_display_name":"Saccomano Nicholas A","owner_url":"/insider/0001609284","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86.0,"shares_display":"86","price_per_share":4.1565,"price_display":"4.16","price_state":"stated","total_value":357.459,"total_display":"357.46","total_whole":"357","shares_owned_after":7333.0,"shares_owned_after_display":"7,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-23","filed_date":"2026-03-24","scope":"insider"},{"id":4122339,"accession":"0001609284-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001609284-25-000004","line_url":"/filing/0001609284-25-000004#line-1","is_derivative":false,"issuer_cik":"0001609284","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001609284","owner_cik":"0001609284","owner_name":"Saccomano Nicholas A","owner_display_name":"Saccomano Nicholas A","owner_url":"/insider/0001609284","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87.0,"shares_display":"87","price_per_share":2.9677,"price_display":"2.97","price_state":"stated","total_value":258.1899,"total_display":"258.19","total_whole":"258","shares_owned_after":7419.0,"shares_owned_after_display":"7,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-23","scope":"insider"},{"id":4032508,"accession":"0001609284-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001609284-25-000003","line_url":"/filing/0001609284-25-000003#line-1","is_derivative":false,"issuer_cik":"0001609284","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001609284","owner_cik":"0001609284","owner_name":"Saccomano Nicholas A","owner_display_name":"Saccomano Nicholas A","owner_url":"/insider/0001609284","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88.0,"shares_display":"88","price_per_share":2.6235,"price_display":"2.62","price_state":"stated","total_value":230.868,"total_display":"230.87","total_whole":"231","shares_owned_after":3506.0,"shares_owned_after_display":"3,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-22","filed_date":"2025-09-24","scope":"insider"},{"id":4434128,"accession":"0001415889-25-018235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-018235","line_url":"/filing/0001415889-25-018235#line-1","is_derivative":false,"issuer_cik":"0001609284","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001609284","owner_cik":"0001609284","owner_name":"Saccomano Nicholas A","owner_display_name":"Saccomano Nicholas A","owner_url":"/insider/0001609284","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88.0,"shares_display":"88","price_per_share":2.3842,"price_display":"2.38","price_state":"stated","total_value":209.8096,"total_display":"209.81","total_whole":"210","shares_owned_after":3594.0,"shares_owned_after_display":"3,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-23","filed_date":"2025-06-25","scope":"insider"},{"id":4281081,"accession":"0001415889-25-010419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-010419","line_url":"/filing/0001415889-25-010419#line-2","is_derivative":false,"issuer_cik":"0001609284","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001609284","owner_cik":"0001609284","owner_name":"Saccomano Nicholas A","owner_display_name":"Saccomano Nicholas A","owner_url":"/insider/0001609284","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":516.0,"shares_display":"516","price_per_share":2.671,"price_display":"2.67","price_state":"stated","total_value":1378.236,"total_display":"1,378.24","total_whole":"1,378","shares_owned_after":3682.0,"shares_owned_after_display":"3,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-07","filed_date":"2025-04-08","scope":"insider"},{"id":4281077,"accession":"0001415889-25-010419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-010419","line_url":"/filing/0001415889-25-010419#line-1","is_derivative":false,"issuer_cik":"0001609284","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001609284","owner_cik":"0001609284","owner_name":"Saccomano Nicholas A","owner_display_name":"Saccomano Nicholas A","owner_url":"/insider/0001609284","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":358.0,"shares_display":"358","price_per_share":3.3276,"price_display":"3.33","price_state":"stated","total_value":1191.2808,"total_display":"1,191.28","total_whole":"1,191","shares_owned_after":4198.0,"shares_owned_after_display":"4,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-04","filed_date":"2025-04-08","scope":"insider"},{"id":7986519,"accession":"0001562180-19-000860","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-19-000860","line_url":"/filing/0001562180-19-000860#line-3","is_derivative":false,"issuer_cik":"0001100412","issuer_name":"ARRAY BIOPHARMA INC","issuer_ticker":"ARRY","issuer_name_source":null,"issuer_url":"/issuer/0001100412","owner_cik":"0001609284","owner_name":"Saccomano Nicholas A","owner_display_name":"Saccomano Nicholas A","owner_url":"/insider/0001609284","role":"Officer (CSO)","role_mark":"O","role_mark_label":"Officer (CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":187264.0,"shares_display":"187,264","price_per_share":21.5832,"price_display":"21.58","price_state":"stated","total_value":4041756.3648,"total_display":"4,041,756.36","total_whole":"4,041,756","shares_owned_after":142488.0,"shares_owned_after_display":"142,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-07","filed_date":"2019-02-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001637715","name":"OnKure Therapeutics, Inc.","url":"/issuer/0001637715","role":"Director, Officer (President and CEO)","n_filings":6,"first_seen":"2025-04-08","last_seen":"2026-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001100412","name":"ARRAY BIOPHARMA INC","url":"/issuer/0001100412","role":"Officer (CSO)","n_filings":1,"first_seen":"2019-02-08","last_seen":"2019-02-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001609284","retrieved_at":"2026-08-22T16:44:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}